Cochlear Limited
CHEOY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 5.37 | 3.15 | 13.00 | -4.18 |
| FCF Yield | 0.69% | 1.41% | 1.77% | 2.30% |
| EV / EBITDA | 31.58 | 36.10 | 30.28 | 29.02 |
| Quality | ||||
| ROIC | 13.45% | 16.22% | 15.40% | 13.17% |
| Gross Margin | 73.74% | 74.86% | 75.05% | 74.96% |
| Cash Conversion Ratio | – | – | 1.21 | 1.30 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.21% | 10.85% | 9.41% | 6.66% |
| Free Cash Flow Growth | -54.85% | 12.20% | -10.96% | 50.63% |
| Safety | ||||
| Net Debt / EBITDA | -0.06 | -0.47 | -0.73 | -0.86 |
| Interest Coverage | 36.92 | 51.63 | 43.87 | 42.06 |
| Efficiency | ||||
| Inventory Turnover | 1.23 | 1.44 | 1.57 | 1.52 |
| Cash Conversion Cycle | 210.52 | 137.52 | 112.39 | 111.08 |